Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
The Lancet. Rheumatology|March 3, 2021
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort studyGiulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, et al.
The Journal of Allergy and Clinical Immunology|July 19, 2019
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related diseaseEmanuel Della-Torre, Elena Rigamonti, Cory Perugino, et al.
Annals of the Rheumatic Diseases|July 5, 2020
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort studyEmanuel Della-Torre, Corrado Campochiaro, Giulio Cavalli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 3, 2018
A CD8α- Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid TreatmentEmanuel Della-Torre, Emanuele Bozzalla-Cassione, Clara Sciorati, et al.
Cancers|July 29, 2023
Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal AdenocarcinomaSabrina Gloria Giulia Testoni, Claudia Minici, Elisa Benetti, et al.
Clinical and Experimental Rheumatology|March 3, 2022
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partnersLuca Iaccarino, Rosaria Talarico, Emanuele Bozzalla-Cassione, et al.
Annals of the Rheumatic Diseases|December 5, 2019
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related diseaseZachary S Wallace, Ray P Naden, Suresh Chari, et al.
The Lancet. Rheumatology|August 25, 2020
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort studyGiacomo De Luca, Giulio Cavalli, Corrado Campochiaro, et al.
The Lancet. Rheumatology|June 6, 2020
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort studyGiulio Cavalli, Giacomo De Luca, Corrado Campochiaro, et al.
United European Gastroenterology Journal|July 22, 2025
Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin-G4-Related Digestive DiseaseMiroslav Vujasinovic, Marco Lanzillotta, Emma L Culver, et al.
Pageof 10